Patent ID: 11957724
Assignee: ERYTECH PHARMA
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C  G  Y | IPC A  C  G

Claim 11:
12. A method for predicting or determining the efficacy of a bacteriophage therapy in a subject and treating said subject, wherein the method comprises:
a) determining in vitro a lytic activity of a composition comprising at least one bacteriophage to an E. coli strain from a sample of said subject, said at least one bacteriophage having lytic activity to an Escherichia coli (E. coli) strain and being selected from the bacteriophages having a genome comprising a nucleotide sequence selected from any one of SEQ ID NOs: 1 to 15 or a sequence having at least 99% identity thereto; and
b) treating the subject with the composition, when in step a) a lytic activity of said composition to at least one E. coli strain from said sample has been determined.